Significance of IFN-ɤ/IL-2 Ratio As a Circulating Diagnostic Biomarker in Extrapulmonary Tuberculosis
Overview
Affiliations
Extrapulmonary tuberculosis (EPTB) remains a challenging diagnosis both for clinicians and microbiologists. We hypothesized that the profile of IFN-ɤ/IL-2 ratio in clinically diagnosed cases of EPTB would be distinct from that of age- and sex-matched healthy controls. Therefore, in our study, we have assessed the ratio of serum levels of IFN-ɤ and IL-2 in clinically diagnosed cases of EPTB to assess their potential role as diagnostic biomarkers. Sixty-nine (69) clinically confirmed EPTB cases and 69 age- and sex-matched healthy controls were included in the study. All the extrapulmonary specimens were subjected to Ziehl-Neelsen staining for acid-fast bacilli and culture on Lowenstein-Jensen (LJ) medium. Detection of serum levels of IFN-ɤ and IL-2 was carried out using commercially available ELISA kits following manufacturers' instructions. The ratio of serum levels of IFN-ɤ and IFN-ɤ/IL-2 was discriminative for the diagnosis of EPTB cases (p < 0.001), although the same was not observed with IL-2 (p > 0.05). Distribution of all biomarkers significantly differed between culture-positive and culture-negative cases (p < 0.05). Among the smear-positive and smear-negative ones, only IFN-ɤ and IFN-ɤ/IL-2 ratio could significantly differentiate (p < 0.05). Ratio of IFN-ɤ and IL-2 rather than the individual levels was the best discriminatory biomarker with the highest area under the ROC curve. Although IFN-ɤ and IFN-ɤ/ IL-2 ratio could aid in the diagnosis of EPTB, IL-2 has a limited utility in the diagnosis of EPTB. Further elaborate studies to validate these results are required.
Gaeddert M, Glaser K, Chendi B, Sultanli A, Koeppel L, MacLean E J Clin Microbiol. 2024; 62(11):e0078624.
PMID: 39445833 PMC: 11559064. DOI: 10.1128/jcm.00786-24.
Wawrocki S, Seweryn M, Kielnierowski G, Rudnicka W, Druszczynska M Saudi J Biol Sci. 2020; 27(11):3035-3045.
PMID: 33100863 PMC: 7569146. DOI: 10.1016/j.sjbs.2020.09.003.
Korma W, Mihret A, Chang Y, Tarekegn A, Tegegn M, Tuha A Diagnostics (Basel). 2020; 10(9).
PMID: 32962082 PMC: 7555064. DOI: 10.3390/diagnostics10090716.
El-Ansary A, Hassan W, Daghestani M, Al-Ayadhi L, Ben Bacha A PLoS One. 2020; 15(1):e0227626.
PMID: 31945130 PMC: 6964874. DOI: 10.1371/journal.pone.0227626.
Wawrocki S, Seweryn M, Kielnierowski G, Rudnicka W, Wlodarczyk M, Druszczynska M PLoS One. 2019; 14(12):e0225556.
PMID: 31821340 PMC: 6903724. DOI: 10.1371/journal.pone.0225556.